… NVAF patients. The aim of this study is to assess the effectiveness and safety of
dabigatran versus warfarin in Japanese NVAF patients who recently initiated drug treatment. …

… The aims of this study were to assess the patterns of oral anticoagulant (OAC) prescription
in Japanese patients with NVAF and compare the effectiveness and safety of dabigatran and …

… Periprocedural dabigatran at a dose of 110 mg twice daily appears to be a safe strategy at
least in Japanese patients undergoing AF ablation with a relatively low risk of thromboembo…

… and the Japanese population. Thus, the efficacy profile of dabigatran over warfarin in
Japanese patients is basically … The primary safety endpoint for this trial was bleeding. In the …

… therapy using dabigatran in Japanese patients with atrial … 184 patients with AF who were
administered dabigatran from April 2011 to August 2012 in our institution. Twenty-eight patients …

… have been reported in some Japanese patients [13]. Thus, the aim of this study was to clarify
the efficacy and safety of anticoagulation with dabigatran in Japanese patients with NVAF. …

… III study, which included Japanese patients, the favorable efficacy and safety of dabigatran
compared to that of INR-adjusted warfarin was demonstrated. The Japanese Guidelines for …

… prescribed dabigatran and other … of Japanese patients with NVAF started on
dabigatran and other antithrombotics as their initial treatment by using data from the J-dabigatran …

… patients may occasionally receive an excessively reduced dose of dabigatran, which is
unapproved in Japan… It has been over 5 years since dabigatran was used clinically in Japan; thus…

… received heparin bridging, which likely affected both safety and efficacy. This study was
conducted in Japanese patients; thus, the findings cannot be generalized to other ethnic …